0000899243-23-002433.txt : 20230123 0000899243-23-002433.hdr.sgml : 20230123 20230123183452 ACCESSION NUMBER: 0000899243-23-002433 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230119 FILED AS OF DATE: 20230123 DATE AS OF CHANGE: 20230123 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rich Cadmus CENTRAL INDEX KEY: 0001890326 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40971 FILM NUMBER: 23545512 MAIL ADDRESS: STREET 1: C/O AURA BIOSCIENCES, INC. STREET 2: 85 BOLTON STREET CITY: CAMBRIDGE STATE: MA ZIP: 02140 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aura Biosciences, Inc. CENTRAL INDEX KEY: 0001501796 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 320271970 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 80 GUEST STREET CITY: BOSTON STATE: MA ZIP: 01235 BUSINESS PHONE: (617)500-8864 MAIL ADDRESS: STREET 1: 80 GUEST STREET CITY: BOSTON STATE: MA ZIP: 01235 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-01-19 0 0001501796 Aura Biosciences, Inc. AURA 0001890326 Rich Cadmus C/O AURA BIOSCIENCES, INC. 80 GUEST STREET BOSTON MA 01235 0 1 0 0 See Remarks Common Stock 2023-01-19 4 A 0 34125 0.00 A 58703 D Stock Option (Right to Buy) 10.18 2023-01-19 4 A 0 52500 A 2033-01-18 Common Stock 52500 52500 D These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on the one year anniversary of the date of grant. The shares underlying this option vest as follows: 25% of the shares vest on the first anniversary of January 19, 2023 with the remainder vesting thereafter pro-rata in 36 monthly installments. Chief Medical Officer, Head of R&D /s/ Julie Feder, as Attorney-in-Fact 2023-01-23